A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24
LINK TO ARTICLE👇👇👇👇👇👇👇👇
sciencedirect.com/science/articl…
The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in
Advanced Prostate Cancer Consensus Conference
11.1K posts
REGISTRATION IS OPEN FOR THE APCCC 2026! APCCC.ORG
APCCC facilitates discussions and debates on advanced prostate cancer diagnostic and treatment options.
- Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial out in @EUplatinum sciencedirect.com/science/articl… The PACE-A trial is a phase 3⃣ randomized study comparing patient-reported outcomes between
- In patients with localized #ProstateCancer who are clinically staged as T2 based on digital rectal examination cN0 cM0 and ISUP GG ≥3 carcinoma and clear evidence of T3 disease on MRI Link:sciencedirect.com/science/articl… The consensus at @APCCC_Lugano 2024 was overwhelmingly in favor
- EAU-EANM- ESTRO -ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent out on @EUplatinum europeanurology.com/article/S0302-… The 2024 European Association of Urology @Uroweb guidelines on clinically localized
- We would like to thank the amazing panel of experts for travelling to #Basel🇨🇭 for the 3rd Advanced Prostate Cancer Consensus Conference APCCC starting tomorrow 29th of August apccc.org Watch out for the conference news @urotoday and the report on @EUplatinum
- ✨ The Advanced Prostate Cancer Consensus Conference (APCCC) 2024 is fast approaching, and we're thrilled to unveil our panel of esteemed global experts! 🌐 Meet the panel shaping the future of prostate cancer care! Join us at #APCCC24 for unparalleled insights and collaborative
- From foes to friends: rethinking the role of lymph nodes in prostate cancer out on @NatRevUrol nature.com/articles/s4158… The therapeutic value of lymph node removal in prostate cancer treatment is debated, as while it aids in disease staging, it may reduce the effectiveness of
- Results after Four Years of Screening for Prostate Cancer with PSA and MRI out on @NEJM nejm.org/doi/full/10.10… This study assessed the efficacy and safety of MRI-based prostate cancer screening in men aged 50 to 60, comparing MRI-targeted biopsy with systematic biopsy. Men
- Full report from #APCCC17 is now published and available open access @EUplatinum bit.ly/2tWmiHd #prostatecancer #urology
- Local Treatment (1ry Tumor and Metastases) in Metastatic Prostate Cancer out on European Urology Focus by @PaulSargos and team sciencedirect.com/science/articl… Over the past decade, advancements in treating mHR #ProstateCancer have improved OS @BenzianeNicolas @AlbertoBossial
- Out now! Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 published on @EUplatinum 👉 europeanurology.com/article/S0302-… #apccc19 #apccc21 #prostatecancer @Els_Urology @urotoday
- Androgen receptor pathway inhibitors and drug–drug interactions in prostate cancer out on @ESMO_Open by @hatice_bolek @coskunyazgann @yekeduz_emre @Silke_Gillessen @DrRanaMcKay @DrYukselUrun sciencedirect.com/science/articl… Androgen receptor pathway inhibitors (ARPIs) 💊are essential
- Prostate Cancer Early Detection in the European Union and UK out on @EUplatinum Comprehensive systematic review analyzes 26 existing reviews on #ProstateCancer (PCa) early detection in the EU 🇪🇺and UK🇬🇧 covering key themes such as invitation, decision-making, screening tests,
















